GenomOncology develops software-based solutions for precision oncology aimed at improving patient outcomes. We aggregate biomarker and clinical data to provide real-time decision support for pathologists, oncologists, and informaticians, accelerating patient recommendations to positively impact patient care.
We build solutions in precision oncology that transform patient care.
Provide best-in-class decision support software
Our therapy recommendations, clinical trial matching, and maximal use of real-world data (e.g. “patients-like-mine”) inform clinicians at the point-of-care. All of our knowledge sets are kept up-to-date and are constantly getting better and better for the best decision support.
Establish comprehensive molecular data infrastructure
In the absence of data standards and inter-operability in genomics, we become the standard for our clients by laying down a molecular data infrastructure platform that is fully extensible and client-specific.
Be the molecular knowledge inside
Our molecular capabilities and our knowledge sets power our oncology solutions. Our platform is flexible enough to integrate with any existing workflow and also be the backend support for a client's own UI solutions.
UNMC partnered with GO to launch the first HL7 2.5 enabled discrete genomic results reporting platform. They will be using GO's complete end-to-end platform for care.
GO's KMS helps power the all-new My Cancer Genome 2.0 website, featuring extensive clinical trial capabilities, updated variant information, and additional visualization tools.
We now offer Genomenon's Mastermind Genomics Search Engine as part of our products enabling clinicians to research and add additional references directly into our point-of-care tools.
Our somatic gene variant annotations and related content are now powered by The Jackson Laboratory Clinical Knowledge base (JAX-CKB™) after partnering with Jackson Labs in 2019.